APMD APMD
Company Profile ↓Company Overview
APMD (APMD) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Return on capital employed stands at 141.6%.
Revenue has grown at a 380.1% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.18.
Recent Developments
- Dec 2025 Revenue of $38.47M (+380.1% YoY); net profit $-932.00K.
- Trailing 12 Months Year-on-year growth — revenue +380.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 380.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 380.12% |
| 1 Year: | 380.12% |
Stock Price Performance
| 1 Year: | +6.04% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 141.6%.
- Compounding revenue at 380.1% over 5 years.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 3.13M | 84.81M |
| Cost of Revenue | 1.32M | 2.16M |
| Gross Profit | 1.81M | 82.65M |
| Operating Expenses | 28.93M | 14.61M |
| Operating Income | -27.11M | 68.04M |
| EBITDA | -27.11M | 68.05M |
| Interest Expense | - | - |
| Pretax Income | -26.68M | 70.37M |
| Tax Provision | 0 | 0 |
| Net Income | -28.65M | 70.37M |
| Diluted EPS | -1.00 | 2.12 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 8.01M | 38.47M |
| Cost of Revenue | 3.37M | 6.69M |
| Gross Profit | 4.64M | 31.77M |
| Operating Expenses | 118.88M | 85.59M |
| Operating Income | -114.23M | -53.82M |
| EBITDA | -114.21M | -53.79M |
| Interest Expense | - | - |
| Pretax Income | -108.55M | -932.00K |
| Tax Provision | 51.00K | 0 |
| Net Income | -111.31M | -932.00K |
| Diluted EPS | -3.87 | -0.03 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Total Assets | 109.22M | 72.87M |
| Current Assets | 73.25M | 45.05M |
| Cash & Equivalents | 68.35M | 41.89M |
| Inventory | - | - |
| Receivables | 1.11M | 959.00K |
| Total Liabilities | 357.84M | 445.66M |
| Current Liabilities | 42.36M | 110.88M |
| Long Term Debt | - | 40.65M |
| Total Debt | 1.09M | 41.52M |
| Total Equity | -248.62M | -372.78M |
| Shares Outstanding | - | - |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | -110.21M | -77.83M |
| Investing Cash Flow | 151.96M | 0 |
| Financing Cash Flow | 51.00K | 51.37M |
| Capital Expenditure | -70.00K | - |
| Free Cash Flow | -110.28M | -77.83M |
| Net Change in Cash | 41.80M | -26.46M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Gross Margin % | 58.0% | 82.6% |
| Operating Margin % | -1,425.8% | -139.9% |
| Net Margin % | -1,389.2% | -2.4% |
| ROE % | 44.8% | 0.3% |
| ROCE % | -170.8% | 141.6% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for APMD
APMD Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFA5eVdQallsR0pqQnZOMndKZy0xYnhHdjBSWWk3VS1sRkg2NkhRRW14OWJqa0RyYVpHVXFzRG5UdEFkT0kweDVHU2FDTF9aNjkw?oc=5" target="_blank">APMD Stock Quote Price and Forecast</a> <font co…
APMD | Apnimed, Inc. Common Stock Insider Trading - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFBEb0ZxMWRzMWJZUEpxQlBTR1o2LTlWdXdJaEpmbkpZWFpwd1hHRERsVjRaUDN2bUJaV1VCdWp1TzRoR1dkeTBaMThYZFlJbm42UkZfSllZdkRyOUYw?oc=5" target="_blank">APMD | Apnimed, Inc. Common Stock Insider T…
Apnimed (APMD) Stock Price, News & Analysis - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFBfNGx4VkpEYl9HX0NUdEoySGZ4UFdiU2JZQy16by1rOWRqcDdURmFHWThPcEYtbUFFZW5PR3RycHZ4X0kyeVh2THNPcEo4UWFMc1JhbVozVk0tdw?oc=5" target="_blank">Apnimed (APMD) Stock Price, News & Analysis</…
Diluted shares outstanding of Apnimed, Inc. – NASDAQ:APMD - TradingView
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNMlBnVjl0ZFljWmMxdG9Bb0ZkbG9SY2JYU05ia25LTFhNUlczcU1HTmMwWGFObXQ2aEk4RnRMRVpRVHQtWmFZaGVudUNHaU8zcW1WWF9rdERIVm50Z0k1TnY0R1JVUG5jVUYyX3MtYjVrUUhlMnRxc2xVYTgzSzczdC1FSTBaQlhTbTVYVW…
APMD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1EX2lfdkI2MDVMSXZHU2p3U0FteVllNjI2Z2dpbnFmZ3BNX1VjdnZ6a0JjQ3h6YTNZeUhnTGJmMmZoV3FQOXNETGQxTEoyZlJXdkJJ?oc=5" target="_blank">APMD Stock News Today | Earnings, Events & Price Alerts…
APMD | Apnimed, Inc. Common Stock Institutional Ownership - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE1oWFN1Mkd0Y281YUViSkJnZkg4WTY0dGpsSE1IVjNvMnNDTTB2THlMcXJ6bXhVZ3luZkJIRUtsSzFEalNVYk5YQmZtRUVmY29qSV9KWlJPalV2bXZwMkYydVN3?oc=5" target="_blank">APMD | Apnimed, Inc. Common Stock I…
APMD — Frequently Asked Questions
What is the current share price of APMD?
As of 2026-08-05 17:25 PDT, APMD trades at $26.51 on NASDAQ/NYSE. Its 52-week range is $25.00 to $26.51.
What is the P/E ratio of APMD?
APMD trades at a trailing price-to-earnings (P/E) ratio of -883.67.
What is the return on equity (ROE) of APMD?
APMD has a return on equity (ROE) of 0.25%. Its return on capital employed (ROCE) is 141.62%.
Is APMD a good stock to buy?
This page provides a data-driven analysis of APMD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.